Anne E. Cress
Affiliations: | University of Arizona, Tucson, AZ |
Area:
Cell Biology, BiochemistryGoogle:
"Anne Cress"Mean distance: (not calculated yet)
Children
Sign in to add traineeManolis C. Demetriou | grad student | 2004 | University of Arizona |
Thomas C. Sroka | grad student | 2005 | University of Arizona |
Sangita C. Pawar | grad student | 2006 | University of Arizona |
Michael O. Ports | grad student | 2009 | University of Arizona |
Apollo D. Kacsinta | grad student | 2010 | University of Arizona |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Paxson AI, Chang LH, Gard JMC, et al. (2023) Phenotype plasticity and altered sensitivity to chemotherapeutic agents in aggressive prostate cancer cells. Frontiers in Cell and Developmental Biology. 11: 1285372 |
Marr KD, Gard JMC, Harryman WL, et al. (2023) Biophysical phenotype mixtures reveal advantages for tumor muscle invasion in vivo. Biophysical Journal |
Jensen CC, Clements AN, Liou H, et al. (2023) PIM1 phosphorylates ABI2 to enhance actin dynamics and promote tumor invasion. The Journal of Cell Biology. 222 |
Marr KD, Ignatenko NA, Warfel NA, et al. (2023) Digital image analysis using video microscopy of human-derived prostate cancer vs normal prostate organoids to assess migratory behavior on extracellular matrix proteins. Frontiers in Oncology. 12: 1083150 |
Ryniawec JM, Coope MR, Loertscher E, et al. (2022) GLUT3/SLC2A3 Is an Endogenous Marker of Hypoxia in Prostate Cancer Cell Lines and Patient-Derived Xenograft Tumors. Diagnostics (Basel, Switzerland). 12 |
Harryman WL, Marr KD, Nagle RB, et al. (2022) Integrins and Epithelial-Mesenchymal Cooperation in the Tumor Microenvironment of Muscle-Invasive Lethal Cancers. Frontiers in Cell and Developmental Biology. 10: 837585 |
Sun BL, Tang L, Sun X, et al. (2021) A Humanized Monoclonal Antibody Targeting Extracellular Nicotinamide Phosphoribosyltransferase Prevents Aggressive Prostate Cancer Progression. Pharmaceuticals (Basel, Switzerland). 14 |
Pollan SG, Teng PC, Jan YJ, et al. (2021) Loss of CDCP1 triggers FAK activation in detached prostate cancer cells. American Journal of Clinical and Experimental Urology. 9: 350-366 |
Kelly GT, Faraj R, Dai Z, et al. (2020) A mutation found in esophageal cancer alters integrin β4 mRNA splicing. Biochemical and Biophysical Research Communications. 529: 726-732 |
Nollet EA, Cardo-Vila M, Ganguly SS, et al. (2020) Androgen receptor-induced integrin α6β1 and Bnip3 promote survival and resistance to PI3K inhibitors in castration-resistant prostate cancer. Oncogene |